Report Detail

Request for Sample of this report

Chemical & Material Global Mesalazine API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4765756
    • |
  • 29 October, 2026
    • |
  • Global
    • |
  • 122 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Mesalazine API market size was valued at US$ 199 million in 2025 and is forecast to a readjusted size of US$ 262 million by 2032 with a CAGR of 4.1% during review period.
Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
In 2024, global Mesalazine API sales reached approximately 5,417 tons, with an average global market price of around US$ 35.0 per kg.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalazine API are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
This report is a detailed and comprehensive analysis for global Mesalazine API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mesalazine API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Mesalazine API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Mesalazine API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Mesalazine API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mesalazine API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mesalazine API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mesalazine API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
Market segment by Application
Tablets
Capsules
Granule
Suppository
Enema
Others
Major players covered
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mesalazine API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mesalazine API, with price, sales quantity, revenue, and global market share of Mesalazine API from 2021 to 2026.
Chapter 3, the Mesalazine API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mesalazine API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mesalazine API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mesalazine API.
Chapter 14 and 15, to describe Mesalazine API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Mesalazine API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity ≥ 97%
    • 1.3.3 Purity ≥ 98%
    • 1.3.4 Purity ≥ 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Mesalazine API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Tablets
    • 1.4.3 Capsules
    • 1.4.4 Granule
    • 1.4.5 Suppository
    • 1.4.6 Enema
    • 1.4.7 Others
  • 1.5 Global Mesalazine API Market Size & Forecast
    • 1.5.1 Global Mesalazine API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Mesalazine API Sales Quantity (2021-2032)
    • 1.5.3 Global Mesalazine API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 PharmaZell
    • 2.1.1 PharmaZell Details
    • 2.1.2 PharmaZell Major Business
    • 2.1.3 PharmaZell Mesalazine API Product and Services
    • 2.1.4 PharmaZell Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 PharmaZell Recent Developments/Updates
  • 2.2 Syntese A/S
    • 2.2.1 Syntese A/S Details
    • 2.2.2 Syntese A/S Major Business
    • 2.2.3 Syntese A/S Mesalazine API Product and Services
    • 2.2.4 Syntese A/S Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Syntese A/S Recent Developments/Updates
  • 2.3 Cambrex Corporation
    • 2.3.1 Cambrex Corporation Details
    • 2.3.2 Cambrex Corporation Major Business
    • 2.3.3 Cambrex Corporation Mesalazine API Product and Services
    • 2.3.4 Cambrex Corporation Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Cambrex Corporation Recent Developments/Updates
  • 2.4 Divis Laboratories
    • 2.4.1 Divis Laboratories Details
    • 2.4.2 Divis Laboratories Major Business
    • 2.4.3 Divis Laboratories Mesalazine API Product and Services
    • 2.4.4 Divis Laboratories Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Divis Laboratories Recent Developments/Updates
  • 2.5 Chemi SpA
    • 2.5.1 Chemi SpA Details
    • 2.5.2 Chemi SpA Major Business
    • 2.5.3 Chemi SpA Mesalazine API Product and Services
    • 2.5.4 Chemi SpA Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Chemi SpA Recent Developments/Updates
  • 2.6 Ipca Laboratories
    • 2.6.1 Ipca Laboratories Details
    • 2.6.2 Ipca Laboratories Major Business
    • 2.6.3 Ipca Laboratories Mesalazine API Product and Services
    • 2.6.4 Ipca Laboratories Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Ipca Laboratories Recent Developments/Updates
  • 2.7 Hangzhou Brother
    • 2.7.1 Hangzhou Brother Details
    • 2.7.2 Hangzhou Brother Major Business
    • 2.7.3 Hangzhou Brother Mesalazine API Product and Services
    • 2.7.4 Hangzhou Brother Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hangzhou Brother Recent Developments/Updates
  • 2.8 Lianyungang Fengheng Biopharm
    • 2.8.1 Lianyungang Fengheng Biopharm Details
    • 2.8.2 Lianyungang Fengheng Biopharm Major Business
    • 2.8.3 Lianyungang Fengheng Biopharm Mesalazine API Product and Services
    • 2.8.4 Lianyungang Fengheng Biopharm Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
  • 2.9 Lasa Loboratory
    • 2.9.1 Lasa Loboratory Details
    • 2.9.2 Lasa Loboratory Major Business
    • 2.9.3 Lasa Loboratory Mesalazine API Product and Services
    • 2.9.4 Lasa Loboratory Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Lasa Loboratory Recent Developments/Updates
  • 2.10 Corden Pharma Bergamo
    • 2.10.1 Corden Pharma Bergamo Details
    • 2.10.2 Corden Pharma Bergamo Major Business
    • 2.10.3 Corden Pharma Bergamo Mesalazine API Product and Services
    • 2.10.4 Corden Pharma Bergamo Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Corden Pharma Bergamo Recent Developments/Updates
  • 2.11 Erregierre SpA
    • 2.11.1 Erregierre SpA Details
    • 2.11.2 Erregierre SpA Major Business
    • 2.11.3 Erregierre SpA Mesalazine API Product and Services
    • 2.11.4 Erregierre SpA Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Erregierre SpA Recent Developments/Updates
  • 2.12 CTX Lifescience
    • 2.12.1 CTX Lifescience Details
    • 2.12.2 CTX Lifescience Major Business
    • 2.12.3 CTX Lifescience Mesalazine API Product and Services
    • 2.12.4 CTX Lifescience Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 CTX Lifescience Recent Developments/Updates
  • 2.13 Ishita Active Pharma Ingredients
    • 2.13.1 Ishita Active Pharma Ingredients Details
    • 2.13.2 Ishita Active Pharma Ingredients Major Business
    • 2.13.3 Ishita Active Pharma Ingredients Mesalazine API Product and Services
    • 2.13.4 Ishita Active Pharma Ingredients Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
  • 2.14 YC Biotech (Jiangsu)
    • 2.14.1 YC Biotech (Jiangsu) Details
    • 2.14.2 YC Biotech (Jiangsu) Major Business
    • 2.14.3 YC Biotech (Jiangsu) Mesalazine API Product and Services
    • 2.14.4 YC Biotech (Jiangsu) Mesalazine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 YC Biotech (Jiangsu) Recent Developments/Updates

3 Competitive Environment: Mesalazine API by Manufacturer

  • 3.1 Global Mesalazine API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Mesalazine API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Mesalazine API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Mesalazine API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Mesalazine API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Mesalazine API Manufacturer Market Share in 2025
  • 3.5 Mesalazine API Market: Overall Company Footprint Analysis
    • 3.5.1 Mesalazine API Market: Region Footprint
    • 3.5.2 Mesalazine API Market: Company Product Type Footprint
    • 3.5.3 Mesalazine API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Mesalazine API Market Size by Region
    • 4.1.1 Global Mesalazine API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Mesalazine API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Mesalazine API Average Price by Region (2021-2032)
  • 4.2 North America Mesalazine API Consumption Value (2021-2032)
  • 4.3 Europe Mesalazine API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Mesalazine API Consumption Value (2021-2032)
  • 4.5 South America Mesalazine API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Mesalazine API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Mesalazine API Sales Quantity by Type (2021-2032)
  • 5.2 Global Mesalazine API Consumption Value by Type (2021-2032)
  • 5.3 Global Mesalazine API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Mesalazine API Sales Quantity by Application (2021-2032)
  • 6.2 Global Mesalazine API Consumption Value by Application (2021-2032)
  • 6.3 Global Mesalazine API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Mesalazine API Sales Quantity by Type (2021-2032)
  • 7.2 North America Mesalazine API Sales Quantity by Application (2021-2032)
  • 7.3 North America Mesalazine API Market Size by Country
    • 7.3.1 North America Mesalazine API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Mesalazine API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Mesalazine API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Mesalazine API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Mesalazine API Market Size by Country
    • 8.3.1 Europe Mesalazine API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Mesalazine API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Mesalazine API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Mesalazine API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Mesalazine API Market Size by Region
    • 9.3.1 Asia-Pacific Mesalazine API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Mesalazine API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Mesalazine API Sales Quantity by Type (2021-2032)
  • 10.2 South America Mesalazine API Sales Quantity by Application (2021-2032)
  • 10.3 South America Mesalazine API Market Size by Country
    • 10.3.1 South America Mesalazine API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Mesalazine API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Mesalazine API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Mesalazine API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Mesalazine API Market Size by Country
    • 11.3.1 Middle East & Africa Mesalazine API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Mesalazine API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Mesalazine API Market Drivers
  • 12.2 Mesalazine API Market Restraints
  • 12.3 Mesalazine API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Mesalazine API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Mesalazine API
  • 13.3 Mesalazine API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Mesalazine API Typical Distributors
  • 14.3 Mesalazine API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Mesalazine API. Industry analysis & Market Report on Mesalazine API is a syndicated market report, published as Global Mesalazine API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Mesalazine API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo